[Mechanism of PI3K/AKT/mTOR signaling pathway for mediating anti-inflammatory and anti-oxidant effects of chrysin: a protein microarray-based study]

Nan Fang Yi Ke Da Xue Xue Bao. 2021 Oct 20;41(10):1554-1561. doi: 10.12122/j.issn.1673-4254.2021.10.15.
[Article in Chinese]

Abstract

Objective: To investigate the mechanism of PI3K/AKT/mTOR signaling pathway for mediating the anti-inflammatory and anti-oxidant effects of chrysin.

Methods: RAW264.7 cells were treated with different concentrations of chrysin for 24 h, and the changes in cell viability were detected using CCK-8 method. The cells with or without chrysin pretreatment for 2 h were stimulated with lipopolysaccharide (LPS) for different lengths of time, and the related signal molecules were screened using protein chip technique. In cells pretreated with chrysin for 2 h followed by LPS stimulation for 18 h, the release of IL-6, MCP-1 and TNF-α by the cells was detected with ELISA, and NO production was examined using Griess method, and ROS level was determined using DCFH-DA. The effects of chrysin, LPS, and their combination on the mRNA expressions of iNOS and COX-2 were detected using RT-PCR; Western blotting was performed to examine the changes in cellular expressions of p-AKT, p-PRAS40, p-mTOR, mTOR, p-P70S6k, p-S6RP and S6RP following the treatments with LPS, N-Acetyl-L-cysteine, and chrysin, alone or in combinations.

Results: Chrysin below 60 μg/mL did not significantly affect the viability of RAW264.7 cells (P>0.05). Chrysin treatment significantly reduced the release of IL-6, MCP-1, and TNF-α and the level of NO (P < 0.01), and inhibited the mRNA and protein expressions of iNOS and COX-2 (P < 0.01) in the cells. The results of protein chip screening suggested that LPS could activate the AKT/mTOR pathway, which was significantly inhibited by chrysin pretreatment, and the results were verified by Western blotting (P < 0.01). Chrysin treatment significantly reduced the generation of endogenous ROS, and treatment with N-Acetyl-L-cysteine to eliminate intracellular ROS obviously reduced the expressions of iNOS and COX-2 (P < 0.05) and blocked the AKT/mTOR pathway (P < 0.05).

Conclusion: Chrysin can inhibit the synthesis of the upstream signaling molecule ROS to inhibit the activation of AKT/mTOR signaling pathway, regulate the translation process of ribosomes, down-regulate the synthesis and release of pro-inflammatory cytokines and inflammatory mediators, and thus produce anti-inflammatory effects.

目的: 探讨PI3K/AKT/mTOR信号通路在白杨素抗炎抗氧化作用中的机制。

方法: 分别用0、5、10、15、30、60、120、240 μg/mL白杨素处理RAW264.7细胞24 h后,CCK-8法检测细胞活力。用白杨素预处理细胞2 h,加入脂多糖(100 ng/mL)分别刺激0、10、30 min,1、2、4、8、16 h,运用蛋白质芯片进行相关信号分子的筛选。用白杨素(10、30、60 μg/mL)孵育细胞2 h后,加入脂多糖刺激18 h,ELISA法检测IL-6,MCP-1和TNF-α的释放量;Griess法检测NO浓度;DCFH-DA荧光探针法检测ROS水平。设立空白对照组,白杨素(60 μg/mL)单独处理组,脂多糖(100 ng/mL)单独刺激组,以及白杨素和脂多糖联合处理组,RT-PCR法检测iNOS和COX-2的mRNA的表达量。分别用脂多糖(100 ng/mL),N-乙酰-半胱氨酸(NAC)(20 μmol/L)或白杨素(10、30、60 μg/mL)单独或共处理细胞后,用Western blot检测炎症相关通路p-AKT、p-PRAS40、p-mTOR、mTOR、p-P70S6k、p-S6RP、S6RP的表达水平。

结果: 白杨素剂量在60 μg/mL内,对细胞活力基本无影响(.05);白杨素能够降低脂多糖刺激诱导的IL-6,MCP-1,TNF-α和炎症介质NO的释放量(P < 0.01),抑制iNOS和COX-2的蛋白表达量和mRNA的表达水平(P < 0.01);蛋白质芯片筛选结果提示,脂多糖能够激活AKT/mTOR信号通路,而白杨素抑制其信号分子的活化,Western blot结果进一步验证了蛋白质芯片的结果(P < 0.01);白杨素显著下调内源性ROS的生成;运用NAC清除细胞内ROS后,炎症蛋白iNOS和COX-2的表达量下调(P < 0.05),而AKT/mTOR通路的活化被阻断(P < 0.05)。

结论: 白杨素通过抑制上游信号分子ROS的合成,进而抑制AKT/mTOR信号通路的活化,调控核糖体的翻译过程,下调促炎细胞因子和炎症介质的合成和释放,发挥抗炎作用。

Keywords: AKT/mTOR; ROS; chrysin; lipopolysaccharide; protein chip.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Antioxidants / pharmacology
  • Cytokines
  • Flavonoids*
  • Lipopolysaccharides / pharmacology
  • Mice
  • Phosphatidylinositol 3-Kinases* / metabolism
  • Protein Array Analysis
  • Proto-Oncogene Proteins c-akt* / metabolism
  • RAW 264.7 Cells
  • Signal Transduction
  • TOR Serine-Threonine Kinases / metabolism

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Cytokines
  • Flavonoids
  • Lipopolysaccharides
  • chrysin
  • Proto-Oncogene Proteins c-akt
  • TOR Serine-Threonine Kinases

Grants and funding

安徽省大学生创新创业训练计划(201910368011,201910368022);安徽高校自然科学研究项目重大项目(KJ2019ZD31,KJ2020ZD54);皖南医学院重点科研项目培育基金(WK2018Z09);活性生物大分子研究安徽省重点实验室项目(1306C083008)